Skip to main content

Ketamine and NMDA-Receptor Antagonists

  • Chapter
  • First Online:
Deer's Treatment of Pain

Abstract

The NMDA receptor plays a significant role in development and maintenance of pain. It is implicated in the development of neuropathic pain, reduced opioid responsiveness, hyperalgesia, and the transition from acute to chronic pain. Hence the NMDA receptor presents an attractive analgesic target for both acute and chronic pain states. This chapter discusses the molecular neurophysiologic mechanisms that mediate the significance of the NMDA receptor. It describes the potential analgesic role of NMDA-receptor antagonists such as ketamine, memantine, amantadine, dextromethorphan, and methadone. The mechanisms, pharmacokinetics, and clinical efficacy of NMDA-receptor antagonists are reviewed in detail. Clinical pearls for the practical use of the NMDA-receptor antagonists are also provided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Recommended Reading

  1. Aiyer R, Mehta N, Gungor S, Gulati A. A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice. Clin J Pain. 2018;34(5):450–67.

    Google Scholar 

  2. Badiola IJ. Can chronic pain be prevented? Anesthesiol Clin. 2016;34(2):303–15.

    Article  Google Scholar 

  3. Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2017;6:CD003351.

    Google Scholar 

  4. Connolly SB, Prager JP, Harden RN. A systematic review of ketamine for complex regional pain syndrome. Pain Med. 2015;16(5):943–69.

    Article  Google Scholar 

  5. Maher DP, Chen L, Mao J. Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization. Anesth Analg. 2017;124(2):661–74.

    Article  CAS  Google Scholar 

  6. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55(9):1059–77.

    Article  CAS  Google Scholar 

  7. Pourmand A, Mazer-Amirshahi M, Royall C, Alhawas R, Shesser R. Low dose ketamine use in the emergency department, a new direction in pain management. Am J Emerg Med. 2017;35(6):918–21.

    Article  CAS  Google Scholar 

  8. Quibell R, Fallon M, Mihalyo M, Twycross R, Wilcock A. Ketamine. J Pain Symptom Manag. 2015;50(2):268–78.

    Article  Google Scholar 

  9. Sawynok J. Topical and peripheral ketamine as an analgesic. Anesth Analg. 2014;119(1):170–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mihir M. Kamdar .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kamdar, M.M. (2019). Ketamine and NMDA-Receptor Antagonists. In: Deer, T., Pope, J., Lamer, T., Provenzano, D. (eds) Deer's Treatment of Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-12281-2_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-12281-2_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-12280-5

  • Online ISBN: 978-3-030-12281-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics